The clinical course and outcomes of post-transplantation diabetes mellitus after heart transplantation

Journal of Korean Medical Science

Volumn 27, Issue 12, 2012, Pages 1460-1467

  Cho, Min Soo ^a   Choi, Hyo In ^a   Kim, In Ok ^a   Jung, Sung Ho ^a   Yun, Tae Jin ^a   Lee, Jae Won ^a   Kim, Min Seok ^a   Kim, Jae Joong ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cardiac allograft vasculopathy; Heart transplantation; Prognosis; PTDM

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; INCIDENCE; INFECTION; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PTDM; REGISTER; SURVIVAL RATE; TREATMENT OUTCOME;

CARDIAC ALLOGRAFT VASCULOPATHY; HEART TRANSPLANTATION; PROGNOSIS; PTDM;

ADULT; COHORT STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INFECTION; MALE; MIDDLE AGED; REGISTRIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84872546964     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.12.1460     Document Type: Article

References (30)

1. Gunnarsson R, Arner P, Lundgren G, Magnusson G, Ostman J, Groth CG. Diabetes mellitus: a more-common-than-believed complication of renal transplantation. Transplant Proc 1979; 11: 1280-1.
2. Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009; 22: 519-30.
3. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588-95.
4. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-85.
5. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440-6.
6. Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, Tolkoff-Rubin N, Pascual M. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066-72.
7. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708-13.
8. Mogollón Jiménez MV, Sobrino Márquez JM, Arizón Muñoz JM, Sánchez Brotons JA, Guguisa Rasco A, Hernández Jiménez MM, Romero Rodríguez N, Borrego Domínguez JM, Ordoñez Fernández A, Lage Gallé E, et al. Incidence and importance of de novo diabetes mellitus after heart transplantation. Transplant Proc 2008; 40: 3053-5.
9. Martínez-Dolz L, Almenar L, Martínez-Ortiz L, Arnau M, Chamorro C, Moro J, Osa A, Rueda J, Garcia C, Palencia M. Predictive factors for development of diabetes mellitus post-heart transplant. Transplant Proc 2005; 37: 4064-6.
10. Depczynski B, Daly B, Campbell LV, Chisholm DJ, Keogh A. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med 2000; 17: 15-9.
11. Nieuwenhuis MG, Kirkels JH. Predictability and other aspects of post-transplant diabetes mellitus in heart transplant recipients. J Heart Lung Transplant 2001; 20: 703-8.
12. Klingenberg R, Gleissner C, Koch A, Schnabel PA, Sack FU, Zimmer-mann R, Katus HA, Dengler TJ. Impact of pre-operative diabetes mellitus upon early and late survival after heart transplantation: a possible era effect. J Heart Lung Transplant 2005; 24: 1239-46.
13. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506-14.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: S62-9.
15. American Diabetes Association. Standards of medical care in diabetes:2011. Diabetes Care 2011; 34: S11-61.
16. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010; 29: 717-27.
17. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-20.
18. Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Kucheryavaya AY, Rahmel AO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant 2009; 28: 1007-22.
19. Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism 2001; 50: 590-3.
20. Lee TH. Prevalence of obesity in Korean non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1996; 32: 71-80.
21. Shin CS, Lee HK, Koh CS, Kim YI, Shin YS, Yoo KY, Paik HY, Park YS, Yang BG. Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care 1997; 20: 1842-6.
22. Marasco SF, Esmore DS, Richardson M, Bailey M, Negri J, Rowland M, Kaye D, Bergin PJ. Prolonged cardiac allograft ischemic time: no impact on long-term survival but at what cost? Clin Transplant 2007; 21: 321-9.
23. Rylski B, Berchtold-Herz M, Olschewski M, Zeh W, Schlensak C, Siepe M, Beyersdorf F. Reducing the ischemic time of donor hearts will decrease morbidity and costs of cardiac transplantations. Interact Cardiovasc Thorac Surg 2010; 10: 945-7.
24. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829-35.
25. Romagnoli J, Citterio F, Violi P, Cadeddu F, Nanni G, Castagneto M. Post-transplant diabetes mellitus: a case-control analysis of the risk factors. Transpl Int 2005; 18: 309-12.
26. Navasa M, Bustamante J, Marroni C, González E, Andreu H, Esmatjes E, Garcia-Valdecasas JC, Grande L, Cirera I, Rimola A, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25: 64-71.
27. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004; 15: 3233-9.
28. Russo MJ, Chen JM, Hong KN, Stewart AS, Ascheim DD, Argenziano M, Mancini DM, Oz MC, Naka Y. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation 2006; 114: 2280-7.
29. Marelli D, Laks H, Patel B, Kermani R, Marmureanu A, Patel J, Kobashigawa J. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 2003; 22: 1091-7.
30. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26: 259-65.